Welcome : Guest

Epigenomics AG (Germany) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Epigenomics AG, which is principally involved in Molecular Diagnostics Business. Illustrated with 77 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-34316
Price: $3500
Company Type: Public
Pages: 80
Date: November 2016
Market Data Tables: 77

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Epigenomics AG's Sales by Geographic Region Worldwide (2015) in Percentage for Europe, North America, and Asia......3
Blood Screening Test......4
Table 2: Blood Screening Test Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Commercial West Nile Virus, Tigris/Spare Parts to Chiron at Cost, Ultrio/Procleix Blood Screening, and Others......4
Bloodstream Infections Tests......5
Table 3: Gram-Negative Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......5
Table 4: Gram-Positive Bloodstream Infections Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......6
Molecular Diagnostics and Genetic Testing......7
Table 5: Spending on Molecular Diagnostics and Genetic Testing by Payer in the US (2015) - Percentage Market Share Breakdown by Value for Cancer, Infectious Diseases, Inhired Conditions and Other......7
Cervical Screening......8
Table 6: Cervical Screening Market by Test Type in Canada (2015) - Percentage Share Breakdown by Value for Conventional Cytology and Liquid-Based Cytology......8
Table 7: Cervical Screening Market by Test Type in Japan (2015) - Percentage Share Breakdown by Value for Conventional Cytology and Liquid-Based Cytology......9
Table 8: Cervical Screening Market by Test Type in the US (2015) - Percentage Share Breakdown by Value for Conventional Cytology and Liquid-Based Cytology......10
Diagnostic Testing......11
Table 9: Diagnostic Test Sales by Category in the US (2015) - Percentage Market Share Breakdown by No. of Solid Tumour Patients for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......11
Table 10: Diagnostic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Ambulatory Physician Services, and Hospital Services......12
Table 11: Diagnostic Testing Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, Inpatient, Outpatient, POLs, and Others......13
Table 12: Diagnostic Testing Sales by Category in the US (2015) - Percentage Share Breakdown by Value for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......14
Table 13: Ambulatory Physician Diagnostics Testing Services Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Hospital Outreach, Independent Labs, POLs, and Others......15
Table 14: Hospital Diagnostics Testing Services Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Outpatient, and Inpatient......16
Genetic Testing......17
Table 15: Genetic Test Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Exome, Mendeliome, Small Panel, and Whole Genome......17
Table 16: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Cancer, Neurology, Pediatric Development, and Others......18
Table 17: Genetic Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Detection, Predisposition, Treatment Selection, Monitoring, and Others......19
Haemoglobin A1C Test......20
Table 18: Haemoglobin A1C Test Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for High Performance Liquid Chromatography (HPLC), and Immunoassy......20
Table 19: Haemoglobin A1C Test Using High Performance Liquid Chromatography (HPLC) Technology by Country Worldwide (2015) - Percentage Market Share Breakdown by Value for United States, and Others......21
Table 20: Haemoglobin A1C Test Using Immunoassay Technology by Country Worldwide (2015) - Percentage Market Share Breakdown by Value for United States, and Others......22
Table 21: Haemoglobin A1C Test Market by Technology in the US (2015) - Percentage Share Breakdown by Value for High Performance Liquid Chromatography (HPLC), and Immunoassy......23
In Vitro Diagnostics......24
Table 22: Clinical In-Vitro Diagnostics Market by Disease Worldwide (2015) - Percentage Share Breakdown by Value for Cancers, Infectious Diseases and Others......24
Table 23: Global In Vitro Diagnostics (IVD) Market by Area (2015) - Percentage Share Breakdown by Value Sales for Clinical Chemistry, Flow Cytometry, Hematology & Blood, Histology & Cytology, Immunoassays, Microbiology & Virology, Molecular Diagnostics and Point-of-Care Testing......25
Table 24: Global IVD Market (2014) in US$ Million......26
Table 25: In Vitro Diagnostics (IVD) Market by Disease Type Worldwide (2015) - Percentage Breakdown by Value for Cancers, Cardio-Vascular Diseases, Infective Diseases, and Others......27
Table 26: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, Flow Cytometry, HBGM, Immunoassay, MDx, and Others......28
Table 27: In Vitro Diagnostics (IVD) Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Cancer, Cardiovascular (CV), Infectious Disease, and Others......29
Table 28: In-Vitro Diagnostics (IVD) Manufacturer Market by Technology Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, HBGM (Home Blood Glucose Monitoring), Immunoassay, MDX (Molecular Diagnostics) and Others......30
Table 29: In-Vitro Diagnostics (IVD) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value for Central Lab, OTC, Self-Test, and Point of Care......31
Table 30: In-Vitro Diagnostics (IVD) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, United States and Others......32
Table 31: In-Vitro Diagnostics Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Chemistry Product, Hematology/Coagulation, Immunoassay Systems and others......33
Table 32: Clinical In-Vitro Diagnostics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, Japan, United States, and Rest of World......34
Table 33: In-Vitro Diagnostic Products Market by Segment in China (2015) - Percentage Share Breakdown by Value for Blood Testing, Cellular Analysis, Clinical Chemistry, Diabetes Testing, Immunoassay, Microbiology, Molecular Diagnostics, and Pathology......35
Table 34: In Vitro Diagnostics (IVD) Laboratory Market by Segment in France (2015) - Percentage Share Breakdown by Value Sales for Instruments, and Reagents......36
Table 35: In Vitro Diagnostics (IVD) Market by Category in France (2015) - Percentage Share Breakdown by Value Sales for Laboratory in Vitro Diagnostics, and Self-Monitoring of Blood Glucose......37
In Vitro Diagnostics (IVD) Laboratory Services......38
Table 36: In-Vitro Diagnostics (IVD) Laboratory Services Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Hospital Labs, Physician Office Labs, Other Independent Labs and Others......38
Table 37: In Vitro Diagnostics (IVD) Laboratory Market by Customer in France (2015) - Percentage Share Breakdown by Value Sales for Etablissement Français du Sang (EFS), Private Laboratories, Public and Private Hospitals, and Others......39
Molecular Diagnostic Genetics Laboratories......40
Table 38: Molecular Diagnostic Genetics Laboratories Market by Assay in the US (2015) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis, Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS Gene) and Others......40
Molecular Diagnostics (MDx)......41
Table 39: Global Molecular Diagnostics (MDx) Market by Infectious Diseases Therapeutic Area (2015) - Percentage Share Breakdown by Value Sales for CT/NG, Healthcare-associated Infections (HAI), Hepatitis, HIV, Respiratory and Others......41
Table 40: Global Molecular Diagnostics (MDx) Market by Region (2015) - Percentage Breakdown by Value Sales for Americas, EMEA and Pacific......42
Table 41: Molecular Diagnostic Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Disease Inherited, Infectious Diseases, Oncology, Prenatal, and Tissue Typing......43
Table 42: Molecular Diagnostics (MDx) Market by Location of Test Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Banks, Hospitals, Near-Patient, and Reference Labs......44
Table 43: Molecular Diagnostics (MDx) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Bacteriology, Blood Screening, Genomics and Virology......45
Table 44: Molecular Diagnostics (MDx) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value Sales for Beads, CE Sequencing, Hybrid Capture, ISH, Microarrays, NGS, PCR, Qpcr, TMA, and Others......46
Table 45: Molecular Diagnostics (MDx) Market by Therapeutic Area Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, CT / NG, HAIs, HLA, HPV, Oncology, Viral Load, and Others......47
Table 46: Molecular Diagnostics (MoDx) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Europe, Japan, Korea, US, and Others......48
Table 47: Molecular Diagnostics Market by Application Worldwide (2015) - Percentage Share Breakdown by Value for Blood Screening, Genetics, Infectious Disease, Oncology and Others......49
Table 48: Molecular Diagnostics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Biochip and Lab-on-a-Chip (LOAC), In Situ Hybridization (ISH), Microarrays, Polymerase Chain Reaction (PCR) and Others......50
Table 49: Molecular Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Infectious Diseases, Inherited Disease, Oncology, Prenatal and Tissue Typing......51
Table 50: Molecular Diagnostics Lab Market by Test Complexity in the US (2015) - Percentage Share Breakdown by Volume for Highly Complex w/LDT, Highly Complex, no LDT and Moderately Complex......52
Table 51: Molecular Diagnostics Lab Market by Test Type in the US (2015) - Percentage Share Breakdown by Volume for Both ID & Genetics, Disease, Only and Infectious......53
Table 52: Molecular Diagnostics Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Blood Screening, Genetic Testing Order, Oncology, Virology and Other Infectious Diseases......54
Molecular Diagnostics (MDx) Infectious Diseases......55
Table 53: Molecular Diagnostics Infectious Diseases Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Active Tuberculosis, Blood Banking, Chlamydia trachomatis (CT), and Neisseria gonorrhoeae (NG), Clostridium difficile, Human Papillomavirus (HPV), Influenza, Panels, S. aureus (SA), and methicillin-resistant S. aureus (MRSA), Viral Load, and Others......55
Molecular Diagnostics (MDx) Laboratories......56
Table 54: Number of Molecular Diagnostics Laboratories by CLIA Complexity in the US (2015) - Percentage Market Share Breakdown for Highly Complex, No Laboratory-Developed Test (LDT), Highly Complex, With Laboratory-Developed Test (LDT) and Moderately Complex......56
Table 55: Number of Molecular Diagnostics Laboratories by Testing Type in the US (2015) - Percentage Market Share Breakdown for Genetics Only, Infectious Disease Only and Both Infectious Disease and Genetics......57
Molecular Diagnostics (MDx) Test......58
Table 56: Molecular Diagnostics Test Market by Type in Europe (2015) - Percentage Share Breakdown by Volume for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), Methicillin-resistant Staphylococcus aureus (MRSA) and Others......58
Pathogen Testing......59
Table 57: Pathogen Testing Market by Category in North America (2015) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Molecular, and Traditional......59
Table 58: Pathogen Testing Market by Segment Worldwide (2015) - Percentage Share Breakdown by Volume for Escherichia Coli, Listeria, Salmonella, and Others......60
Table 59: Pathogen Testing Market by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Culture, Immunochemical, and Molecular......61
Table 60: Pathogen Testing Market by Category in Asia (2015) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Convenience, Molecular, and Traditional......62
Table 61: Pathogen Testing Market by Category in European Union (EU) (2015) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Molecular, and Traditional......63
Forensics Testing......64
Table 62: Forensics Testing Market by Category in the US (2015) - Percentage Share Breakdown by Value for DNA, Fingerprints, and Others......64
Blood Screening Test......65
Table 63: Market Shares of Leading Blood Screening Test Companies by Value Sales Worldwide (2015) - Percentage Breakdown for F. Hoffmann-La Roche AG, Gen-Probe, Inc., and Others......65
Blood Glucose Diagnostics Equipment......66
Table 64: Market Shares of Leading Blood Glucose Diagnostics Equipment Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche AG, LifeScan, Inc., and Others......66
In Vitro Diagnostics (IVD)......67
Table 65: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Alere, Inc., Danaher Corporation, LifeScan, Inc., Roche Holdings, Inc., System Industrie Electronic GmbH, Thermo Fisher Scientific, Inc., and Others......67
Table 66: Market Shares of Leading In Vitro Diagnostics (IVD) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), Bayer AG (BAYN), Becton, Dickinson and Company (BDX), BioMerieux SA (BIM), Bio-Rad Laboratories, Inc. (BIO), Danaher Corporation (DHR), Hologic, Inc. (HOLX), LifeScan, Inc., Ortho-Clinical Diagnostics, Inc., Rogers Corporation (ROG), Siemens AG (SIE), Sysmex Corporation, Thermo Fisher Scientific (TMO), Werfen Group, and Others......68
Table 67: Market Shares of Leading In Vitro Diagnostics (IVD) Instrumentation (Mid to High throughput Analyzer) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Hitachi, Ltd., Invetech, KMC Systems Inc., Stratec Biomedical AG, Tecan Group Ltd., and Others......69
Table 68: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers in China (2015) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Mindray Medical International Limited, Roche Holdings, Inc., and Others......70
Table 69: Market Shares of Leading In Vitro Diagnostics (IVDs) Companies in the US (2014) - Percentage Share Breakdown by Value for Abbott Laboratories, BioMérieux, Danaher Corporation, The, F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, and Others......71
Cancer Genetic Diagnostics......72
Table 70: Market Shares of Leading Cancer Genetic Diagnostics Reference Laboratory Services in the US (2015) - Percentage Breakdown by Value Sales for ARUP Laboratories, Clarient Diagnostic Services, Inc., Laboratory Corporation of America Holdings, Mayo Medical Laboratories, NeoGenomics, Inc., Quest Diagnostics Incorporated and AmeriPath, Inc., and Others......72
Molecular Diagnostics (MDx)......73
Table 71: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......73
Table 72: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......74
Pathogen Testing......75
Table 73: Market Shares of Leading Pathogen Testing Equipment Brands Worldwide (2014) - Percentage Share Breakdown by Value for 3M Petrifilm, BioMerieux VIDAS, DuPont BAX, and Others......75
Urine Test......76
Table 74: Market Shares of Leading Urine Test/Kit Brands through Supermarkets, Drug Stores, Mass Merchandisers (including Wal-Mart) Military Commissaries and Select Dollar and Club Chains in the US (2015) - Percentage Breakdown by Value for Azo Test Strips, Uristat, and Others......76
Diagnostic Testing......77
Table 75: Market Shares of Leading Diagnostic Testing Companies in the US (2015) - Percentage Share Breakdown by Value for Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated and Others......77
Table 76: Epigenomics AG's Sales by Segment in Germany (2015) - Percentage Market Share Breakdown by Value for Licensing Income, Research and Development Income, and Others......78
Table 77: Epigenomics AG’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for Europe, North America, Asia and Rest of the World......79